EIGHT NEW CONTRACT WINS FOR EXEL COMPANY PHARMA LOGISTICS 12 MONTHS SINCE ACQUISITION

Exel, the global leader in supply chain management, has announced that it has won eight new healthcare contracts in Italy in the 12 months since the acquisition of Pharma Logistics. The new contracts include business with Becton Dickinson, ZLB Behring, Hollister, DePuy (J&J) in the medical device sector, and Lundbeck and AstraZeneca in the pharmaceutical sector, gained by the Pharma Logistics' team, have strengthened Exel's operations in Italy and confirmed Exel's growth strategy in this key European market.

With eight facilities and 350 employees, Exel has developed broader capabilities in Pharma Logistics' existing markets since the acquisition. The new business sees the Company providing integrated warehousing and distribution, chilled distribution, quarantine storage and value-added services, such as sales order processing, customer service, relabelling and invoicing.

Through Pharma Logistics, Exel has established a strategic partnership with Becton Dickinson to manage the Company's logistics operations across Italy through Pharma Channel, an innovative solution providing e-business solutions and services dedicated to pharmacies. Pharma Channel acts as an intermediary between pharmacies and pharmaceutical manufacturers and services include customer service, call centres, order management, invoicing, credit management and information management.

Anthony Mitchell, Senior Vice President for Development, Exel's Healthcare business, commented, "The acquisition of Pharma Logistics delivers local capability to our customers in the important Italian marketplace and enhances our pan-European offering. These new contracts, won since the acquisition of Pharma Logistics, demonstrate the importance to those customers seeking a regional solution for their logistics' needs."

Exel has also strengthened relationships with existing customers. Since the acquisition, the Company has extended its relationship with AstraZeneca, providing warehousing and distribution of the Rosuvastatina brand across Italy. The Company has also built upon an existing relationship with the Wyeth Group, becoming the logistics partner to Wyeth subsidiaries Fort Dodge and Wyeth Consumer Healthcare SpA.

Eddy de Vita, Managing Director of Pharma Logistics, concluded, "Since joining the Exel family we have further consolidated our existing business providing our customers with a large range of services in a wider geographical area as well as gaining significant new business."

EXEL Healthcare Europe, Middle East and Africa (EMEA) Brochure

Exel has established customer partnerships across Europe with companies in every segment of the healthcare market. This includes dedicated and shared-user solutions for pharmaceutical, medical device, over-the-counter (OTC), consumer healthcare manufacturers and hospitals. Exels Healthcare capability is integrated with global freight management, so that customers benefit from end-to-end supply chain management through a single point of contact.